Thomas D. Brown

9.7k citations

123 papers · 4.8k indexed · 2 hit papers · h-index 35

Impact in

Orthopedics and Sports Medicine top 1%
- Tendon Structure and Treatment
- Foot and Ankle Surgery
Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Orthopedics and Sports Medicine 13
- Tendon Structure and Treatment 7
Bioengineering 8
- Analytical Chemistry and Sensors 8

Co-authors: Joseph A. Buckwalter Charles L. Saltzman James L. Abbruzzese Paul R. Ohodnicki Qiang Tian Leroy Hood Changting Meng Chunmei Bai
Journals: Journal of Clinical Oncology (12 papers)Investigational New Drugs (10 papers)Clinical Orthopaedics and Related Research (7 papers)Anti-Cancer Drugs (6 papers)Cancer Research (6 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Thomas D. Brown

114 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Human Gut Microbiota and Gastrointestinal Cancer 2018 · 313 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Genomics Proteomics & Bioinformatics
2004 Clinical Orthopaedics and Related Research

Peers

Countries citing papers authored by Thomas D. Brown

Since Specialization

Citations

This map shows the geographic impact of Thomas D. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Brown more than expected).

Fields of papers citing papers by Thomas D. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Brown. The network helps show where Thomas D. Brown may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas D. Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas D. Brown Line = papers co-authored together Thomas D. Brown links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Improvements in Clinical Cancer Care Associated with Integration of Personalized Medicine Journal of Personalized Medicine ·Carolina Gómez-Navia, Daryl Pritchard, J. Jelinek, Kathleen Wittgen, Thomas D. Brown, Leonardo de Albuquerque Moraes	2024	0
2	Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer JNCI Cancer Spectrum ·Molly Scannell Bryan, Xiaohan Hu, Monika A. Izano, Kathleen Wittgen, Jade Andrade Malta Santos, Thomas D. Brown, George R. Simon, Henry G. Kaplan, Anna B. Berry	2024	0
3	Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia Journal of Allergy and Clinical Immunology ·Paneez Khoury, Michelle Makiya, Frithjof Trapp, Göran Djupsund, D. Nicolás Espinoza, Adam Schiffenbauer, Costanza Natali, Charles E. Anderson, Gregory Constantine, Irina Marić, Xiaoping Sun, Stefania Pittaluga, Thomas D. Brown, JeanAnne Ware, Lauren Wetzler, Michael P. Fay, Amy D. Klion	2023	3
4	Hands-On Photonic Education Kits: empowering the integrated photonics workforce through practical training Applied Optics ·Nasir Ahmad Bhat Rafia Hassan, Tan Zhimin, Nurraudya Tuz Zahra, Kazuhito Horikiri, Aura Jalal, Weihua Hu, D. V Incenzi, Cobo Benitez, O. N. Shadrin, Jelena Notaroš, Samuel Serna, Jaime Cárdenas, Thomas D. Brown, Anu Agarwal, Инна Александровна Павленко, Stefan F. Preble	2023	1
5	Epidemiology of interstitial lung disease in patients with metastatic breast cancer at baseline and after treatment with HER2-directed therapy: a real-world data analysis Breast Cancer Research and Treatment ·Julia Rodrigues Ferreira Gomes, Alicyn Campbell, Hariom Bijamwar, Colden Johanson, 杨海滨, Elisabeth Piault, Monika A. Izano, Anette Schrag, M. V. da Silva, Thomas D. Brown, Henry G. Kaplan	2022	4
6	Implementing Real-World RECIST-based Tumor Response Assessment in Patients With Metastatic Non-small Cell Lung Cancer Clinical Lung Cancer ·Monika A. Izano, M.A.G. Lewin, Alan Fu, L. F. Zajnetdinova, Merten Siegfried, Gita Marcelina Novitasari, Huakang Tu, Tian-xiao, Anna Stará, Matthew J. Rioth, Thomas D. Brown	2022	8
7	A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan Clinical Cancer Research ·Valerie Lee, Judy Wang, Marianna Zahurak, Elske C. Gootjes, Henk M.W. Verheul, Rose Parkinson, Zachary Kerner, Anup Sharma, Gary L. Rosner, Ana De Jesus‐Acosta, Daniel A. Laheru, Dung T. Le, Aram Oganesian, Oswaldo Chicaiza N., Thomas D. Brown, Peter A. Jones, Stephen B. Baylin, Nita Ahuja, Monica Vargas Solla	2018	39
8	Going the distance for breast health. Mobile mammography allows more women to be screened, increases early detection. PubMed ·Thomas D. Brown	2013	3
9	Plasmonic nanocomposite thin film enabled fiber optic sensors for simultaneous gas and temperature sensing at extreme temperatures Nanoscale ·Paul R. Ohodnicki, Michael Buric, Thomas D. Brown, Christopher Matranga, Congjun Wang, John P. Baltrus, Mark Andio	2013	78
10	Objective CT-Based Metrics of Articular Fracture Severity to Assess Risk for Posttraumatic Osteoarthritis Journal of Orthopaedic Trauma ·Thaddeus P. Thomas, Donald D. Anderson, 曾章琴, Carmen Padilla, Stephen L. Hillis, J. Lawrence Marsh, Thomas D. Brown	2010	35
11	A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma Journal of Cancer Research and Clinical Oncology ·Yasser Buchana, Richard D. Lozano, Thomas D. Brown, Yehuda Z. Patt, Takashi Arima, James L. Abbruzzese, Melanie B. Thomas	2008	21
12	Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma Cancer ·Melanie B. Thomas, Romil Chadha, Katrina Y. Glover, Xuemei Wang, Jeffrey S. Morris, Thomas D. Brown, Asif Rashid, Janet Dancey, James L. Abbruzzese	2007	235
13	Thalidomide in the treatment of patients with hepatocellular carcinoma Cancer ·Yehuda Z. Patt, Manal M. Hassan, Richard D. Lozano, Ajay K. Nooka, Tesalonika Dameria Marpaung, Jerome B. Zeldis, James L. Abbruzzese, Thomas D. Brown	2005	75
14	Tensile Engagement of the Peri-Ankle Ligaments in Stance Phase Foot & Ankle International ·Yuki Tochigi, Maximilian Rudert, Annunziato Amendola, Thomas D. Brown, Charles L. Saltzman	2005	33
15	Cartilage Thickness in Cadaveric Ankles: Measurement with Double-Contrast Multi–Detector Row CT Arthrography versus MR Imaging Radiology ·Georges Y. El-Khoury, Kyle J. Alliman, Hannah J. Lundberg, Masayuki MUKO, Thomas D. Brown, Charles L. Saltzman	2004	80
16	Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas Investigational New Drugs ·Ephraim S. Casper, Mark R. Green, David P. Kelsen, Robert T. Heelan, Thomas D. Brown, Carlos D. Flombaum, Bonnie J. Trochanowski, Peter G. Tarassoff	1994	372
17	A phase I trial of trimetrexate (NSC352122) on a daily × 5 schedule in patients with refractory adult leukemia Anti-Cancer Drugs ·Gladys Rodriguez, Thomas D. Brown, Frank M. Balis, John B. Craig, Claude Denham, John G. Kuhn, Kathleen A. Havlin, Daniel D. Von Hoff	1993	3
18	Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study Anti-Cancer Drugs ·Thomas D. Brown, Phyllis J. Goodman, Chris Sinha, John S. Macdonald, John B. Craig, Albert Einstein	1993	2
19	High incidence of coagulopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers Anti-Cancer Drugs ·Franco M. Muggia, Thomas D. Brown, Phyllis J. Goodman, John S. Macdonald, Evan M. Hersh, Thomas R. Fleming, Lawrence Leichman	1992	11
20	Phase II Trial of Recombinant DNA ?? -Interferon in Advanced Colorectal Cancer: A Southwest Oncology Group Study Journal of Immunotherapy ·Thomas D. Brown, Phyllis J. Goodman, Chris Sinha, John S. Macdonald, Luis Mariano Herrero Hermida, Sarah A. Taylor, John R. Neefe, Ellen R. Gaynor	1991	4

About Thomas D. Brown

Thomas D. Brown is a scholar working on Orthopedics and Sports Medicine, Bioengineering, Oncology, Cancer Research and Hepatology, having authored 123 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Gas Sensing Nanomaterials and Sensors (10 papers), Orthopedic Surgery and Rehabilitation (9 papers), Analytical Chemistry and Sensors (8 papers), Tendon Structure and Treatment (7 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Orthopedics and Sports Medicine (692 citations), Hepatology (445 citations), Oncology (1.3k citations), Rheumatology (633 citations) and Surgery (1.4k citations). Thomas D. Brown has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Joseph A. Buckwalter, Charles L. Saltzman, James L. Abbruzzese, Paul R. Ohodnicki, Qiang Tian, Leroy Hood, Changting Meng, Chunmei Bai, Steven A. Curley and Mark R. Green. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Clinical Orthopaedics and Related Research, Anti-Cancer Drugs and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact